Press Releases :: XORTX Therapeutics Inc. (XRTX)

Apr 17, 2025 7:45pm EDT

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Mar 19, 2025 7:00am EDT

XORTX Announces Update for Discussion with the FDA

Feb 24, 2025 7:00am EST

XORTX Commences Gout Program NDA Discussions with the FDA

Jan 29, 2025 7:00am EST

XORTX to Present at Microcap Conference

Jan 17, 2025 5:00pm EST

XORTX Announces Change of Auditor

Jan 06, 2025 7:00am EST

XORTX Adds Late Stage Gout Program to Pipeline

rss_feed News RSS